The appearance of MCI in patients with NAFLD is associated with higher plasma levels of several pro-inflammatory and anti-inflammatory cytokines and with an abnormal differentiation of CD4+ T-helper subsets. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.